GlassScriptPhysician profile
Heather Sullivan
NPI 1144692823
$27,819.74
in general payments reported to CMS, 2019-2025
33 companies · $4,655 in 2025
The $4,655 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,102 · 2022: $6,051 · 2023: $6,377 · 2024: $5,634 · 2025: $4,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,558.36 |
| Education | $107.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $5,053.83 | 2021-2025 | Tavneos, Enbrel, Krystexxa |
| Abbvie INC. | $3,440.63 | 2021-2025 | |
| Ucb, INC. | $2,836.00 | 2021-2025 | Cimzia, Bimzelx |
| Astrazeneca Pharmaceuticals LP | $2,382.17 | 2021-2025 | Saphnelo |
| Glaxosmithkline, LLC. | $1,650.08 | 2021-2025 | Benlysta |
| Novartis Pharmaceuticals Corporation | $1,631.09 | 2021-2025 | |
| Janssen Biotech, INC. | $1,607.60 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Horizon Therapeutics Plc | $1,581.06 | 2021-2023 | Krystexxa |
| Lilly USA, LLC | $1,172.47 | 2021-2025 | Taltz |
| E.R. Squibb & Sons, L.L.C. | $831.73 | 2021-2025 | Orencia, Sotyktu |
| Genentech USA, INC. | $788.03 | 2021-2025 | Actemra, Rituxan, Gazyva |
| Mallinckrodt Hospital Products INC. | $779.14 | 2021-2025 | Acthar |
| Radius Health, INC. | $764.32 | 2021-2025 | Tymlos |
| Pfizer INC. | $703.57 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $608.34 | 2021-2025 | Ofev, Cyltezo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $606.68 | 2022-2025 | Purified Cortrophin Gel |
| Janssen Scientific Affairs, LLC | $276.99 | 2021-2025 | Tremfya |
| Daiichi Sankyo INC. | $188.92 | 2021-2024 | Injectafer |
| Sandoz INC. | $171.52 | 2023-2024 | Hyrimoz |
| Alexion Pharmaceuticals, INC. | $164.87 | 2024-2025 | Strensiq |
| Genzyme Corporation | $153.68 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $94.56 | 2022-2025 | Opsynvi |
| Sobi, INC | $54.98 | 2025 | |
| Mylan Institutional INC. | $52.55 | 2023 | Hulio |
| Depuy Synthes Sales INC. | $52.09 | 2025 | Monovisc |
| Organon LLC | $42.93 | 2022-2025 | Hadlima, Renflexis |
| Biocon Biologics INC | $25.59 | 2024 | Hulio |
| Aurinia Pharma U.S., INC. | $19.78 | 2024 | Lupkynis |
| Idorsia Pharmaceuticals US INC | $19.05 | 2023 | Quviviq |
| Bioventus LLC | $17.59 | 2023 | Durolane |
| Alvogen INC | $17.34 | 2024 | Teriparatide |
| Ultragenyx Pharmaceutical INC. | $16.43 | 2021 | |
| Tersera Therapeutics LLC | $14.13 | 2025 | Quzyttir |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.